Genomic Vision Aktie

Génomic Vision SA is a molecular diagnostics and technology company, which develops and commercializes research tools and tests for the early detection of cancers and genetic diseases. The firm's products include molecular combing platform and genomic morse code sets. The company was founded by Aaron Bensimon and Daniel Nerson on June 11, 2004 and is headquartered in Bagneux, France.